Gastroenterology · Liver Disease
The facts most likely to be tested
The hepatic venous pressure gradient (HVPG) is the gold standard for measuring portal pressure, with clinically significant portal hypertension defined as a gradient ≥ 10 mmHg.
Esophageal varices are the most life-threatening complication of portal hypertension, requiring screening esophagogastroduodenoscopy (EGD) in all patients with newly diagnosed cirrhosis.
Non-selective beta-blockers (e.g., propranolol, nadolol) are the first-line pharmacologic therapy for the primary prophylaxis of variceal hemorrhage by reducing portal venous pressure.
Acute variceal hemorrhage requires immediate resuscitation, prophylactic antibiotics (e.g., ceftriaxone) to prevent spontaneous bacterial peritonitis, and octreotide to induce splanchnic vasoconstriction.
Ascites is the most common clinical manifestation of portal hypertension, caused by a combination of splanchnic vasodilation and sodium/water retention.
The serum-ascites albumin gradient (SAAG) is calculated as (serum albumin - ascitic fluid albumin), where a value ≥ 1.1 g/dL indicates portal hypertension as the etiology.
Transjugular intrahepatic portosystemic shunt (TIPS) is the definitive intervention for refractory ascites or recurrent variceal bleeding despite endoscopic and pharmacologic therapy.
Vignette unlocked
A 54-year-old male with a history of alcohol use disorder presents to the emergency department after vomiting a large amount of bright red blood. Physical examination reveals scleral icterus, palmar erythema, and a distended abdomen with a fluid wave. His blood pressure is 90/60 mmHg and heart rate is 115 bpm. Laboratory studies show a thrombocytopenia of 85,000/µL and an elevated INR.
What is the most appropriate initial pharmacologic intervention to reduce portal pressure in this patient?
Octreotide
The patient is presenting with an acute variceal hemorrhage; octreotide is the standard of care to reduce splanchnic blood flow and portal pressure, as described in the fourth bet.
Full handout
High yield triage
Etiology / Epidemiology
Most commonly caused by cirrhosis (alcohol, viral hepatitis, NASH). Increased resistance to portal venous flow leads to collateral circulation.
Clinical Manifestations
Classic triad: ascites, splenomegaly, and variceal hemorrhage. Look for caput medusae and palmar erythema.
Diagnosis
Gold standard is hepatic venous pressure gradient (HVPG). Portal hypertension is defined as HVPG > 5 mmHg; clinically significant at > 10 mmHg.
Treatment
Primary prophylaxis for varices is non-selective beta-blockers (e.g., nadolol). Avoid in cardiogenic shock; use octreotide for acute bleeds.
Prognosis
High mortality with variceal hemorrhage. Monitor for spontaneous bacterial peritonitis (SBP) and hepatorenal syndrome.
Full handout
Epidemiology & Etiology
Cirrhosis is the leading cause in Western populations, primarily due to alcohol use disorder and HCV/HBV infection. Non-cirrhotic causes include portal vein thrombosis and Budd-Chiari syndrome. Chronic liver inflammation leads to fibrosis and architectural distortion.
Pertinent Anatomy
The portal vein is formed by the union of the superior mesenteric and splenic veins. Obstruction forces blood into low-pressure systemic collaterals, specifically the esophageal, umbilical, and hemorrhoidal veins.
Pathophysiology
Increased intrahepatic resistance combined with increased splanchnic blood flow creates a hyperdynamic state. Elevated pressure leads to portosystemic shunting and systemic vasodilation. This triggers the renin-angiotensin-aldosterone system (RAAS), causing sodium and water retention, manifesting as ascites.
Clinical Manifestations
Patients present with caput medusae, spider angiomata, and splenomegaly. Hematemesis or melena indicates ruptured esophageal varices, a life-threatening emergency. Watch for fetor hepaticus and altered mental status suggesting hepatic encephalopathy.
Diagnosis
The hepatic venous pressure gradient (HVPG) is the gold standard. A gradient > 5 mmHg confirms portal hypertension, while > 10 mmHg predicts variceal formation. EGD (esophagogastroduodenoscopy) is mandatory for screening varices in all new cirrhosis diagnoses.
Treatment
Primary prophylaxis for large varices involves non-selective beta-blockers (propranolol or nadolol) to reduce portal pressure. Acute variceal hemorrhage requires octreotide infusion and prophylactic antibiotics (e.g., ceftriaxone). Do not use beta-blockers in acute hemorrhage due to risk of hypotension.
Prognosis
Complications include spontaneous bacterial peritonitis (SBP), defined by ascitic fluid PMN count > 250 cells/mm³. Hepatorenal syndrome is a terminal complication characterized by rapid renal failure in the absence of other causes.
Differential Diagnosis
Budd-Chiari syndrome: hepatic vein thrombosis with classic triad of abdominal pain, ascites, and hepatomegaly
Right-sided heart failure: elevated JVP and hepatojugular reflux distinguish from liver-origin portal hypertension
Constrictive pericarditis: Kussmaul sign and pericardial calcification on imaging
Portal vein thrombosis: sudden onset in patients without cirrhosis, often hypercoagulable state
Schistosomiasis: common cause of pre-hepatic portal hypertension in endemic regions